In particular, while patients with PMF and type 2-like mutation mimicked the ET phenotype in terms of thrombocytosis, they tended to exhibit a higher leukocyte count and CALR mutant burden than patients with ET and the same CALR mutant type. This evidence concerns the gene CALR and thrombocytosis disease.